01564nam 2200445 450 991070812840332120130205103042.0(CKB)4970000000026316(OCoLC)826713750(EXLCZ)99497000000002631620130205d2012 ua 0engurmn|||||||||rdacontentrdamediardacarrierEnd-stage renal disease reduction in drug utilization suggests bundled payment is too high /James CosgroveRevised.Washington, DC :United States Government Accountability Office,2012.1 online resource (14 pages) color illustrationTitle from title screen (viewed Feb. 4, 2013)."December 7, 2012."Includes errata statement."GAO-13-190R."Includes bibliographical references.End-stage Renal DiseaseMedicareEconomic aspectsMedicareClaims administrationChronic renal failureTreatmentEconomic aspectsUnited StatesMedicareEconomic aspects.MedicareClaims administration.Chronic renal failureTreatmentEconomic aspectsCosgrove James C.1395889United States.Government Accountability Office,GPOGPODOCUMENT9910708128403321End-stage renal disease3483401UNINA